Evidence map›Paper›PMID 27313634›Full record

ArticleHepatitis monthly2016

Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital.

Charles Asabamaka Onyekwere, Anthonia O Ogbera, Akinola Olusola Dada, Olufunke O Adeleye, Adedoyin O Dosunmu, Akinsegun A Akinbami, Bodunrin Osikomaiya, Oladipupo Hameed

Open access · hybridAbstract read
In one paragraph

Article in Hepatitis monthly, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Charles Asabamaka OnyekwereDepartment of Medicine, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Anthonia O OgberaDepartment of Medicine, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Akinola Olusola DadaDepartment of Medicine, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Olufunke O AdeleyeDepartment of Medicine, Ogun State University Medical School, Ago-Iwoye, Nigeria.
Adedoyin O DosunmuDepartment of Hematology, LASUTH, Lagos, Nigeria.
Akinsegun A AkinbamiDepartment of Hematology, LASUTH, Lagos, Nigeria.
Bodunrin OsikomaiyaDepartment of Hematology, LASUTH, Lagos, Nigeria.
Oladipupo HameedDepartment of Medical Affairs, Roche Pharma (PLC), Lagos, Nigeria.
Lagos State University · NGLagos State University Teaching Hospital · NGOlabisi Onabanjo University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the advent of highly effective anti-hepatitis C virus (HCV) drugs, efforts to identify infected cases, high-risk groups, and associated risk factors have become the focus of current control measures.

objectivesTo determine the prevalence of the HCV antibody among diabetics and patients with lymphoproliferative disorders (LPD) who presented to the outpatient clinics of a university hospital and its associated risk factors. PATIENTS AND

methodsConsecutively consenting patients who had been previously diagnosed with diabetes mellitus and LPD at the outpatient department of the Lagos State University teaching hospital were recruited. A case record form was used to extract their demographics and physical examination findings as well as any risk factors for HCV infection; blood was also drawn to run a serological assay for the HCV antibody. All data were collated and analyzed using the Statistical Package for the Social Sciences version 20. Student T-test, Chi square, and logistic regression were some of the inferential statistics used in addition to descriptive statistics.

resultsIn all, 438 patients (405 diabetics and 33 patients with LPD) were recruited. Their ages ranged from 17 - 87 years with a mean + Standard deviation of 59.61 + 11.859 years. The prevalence of hepatitis C among the diabetic subgroup was 0.7%, while the antibody was present in 9.1% of the LPD patients. The occurrence of the HCV antibody was, however, not significantly associated with age, sex, educational level, or marital status (P > 0.05). Having multiple sexual partners was identified as the only significant risk factor for hepatitis C (OR = 9.148; P = 0.017).

conclusionsThis survey suggested that a higher HCV prevalence exists in this population than is currently reported in the general population, and having sex with multiple partners was a risk factor for HCV infection.

Indexed as

Diabetes MellitusHepatitis C PrevalenceLymphoproliferative Disorders

Identifiers

PMID27313634
PMCPMC4908612
OpenAlexW2344888812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.